目的 评估远程黄疸监测系统在新生儿高胆红素血症居家筛查中的临床应用价值及转化潜力。 方法 采用前瞻性自身配对研究设计，纳入2023年3—10月南京医科大学附属妇产医院538例胎龄≥35周、体重≥2 000 g、日龄≤14 d的新生儿。基于“中国新生儿小时经皮胆红素百分位曲线图”制订4种不同预测指标的筛查方案，评估系统效能，分析远程黄疸监测系统在真实家庭环境中使用的可行性。 结果 538对经皮胆红素与血清总胆红素配对值显示，两者显著相关（r=0.85，P<0.001），95.0%（511/538）的样本位于95%一致性界限内。以经皮胆红素值≥第95百分位数为预测指标，灵敏度达100%，特异度为46.2%，受试者操作特征曲线下面积为0.731（95%CI：0.682~0.780），可减少41.4%（221/538）非必要就诊。 结论 该系统整合QBH-801经皮黄疸仪、智能预警及远程指导服务，构建“医院-家庭”闭环管理模式，具备高安全性与可行性，临床转化价值显著。

Objective To evaluate the clinical utility and translational potential of a remote jaundice monitoring system for home-based screening of neonatal hyperbilirubinemia. Methods A prospective self-controlled study was conducted, enrolling 538 newborns with gestational age ≥35 weeks, birth weight ≥2 000 g, and postnatal age ≤14 days at the Women's Hospital of Nanjing Medical University from March to October 2023. Four screening protocols with different predictive indicators were developed based on the Chinese Neonatal Transcutaneous Hourly Bilirubin Nomogram. The effectiveness of the system was evaluated, and the feasibility of using the remote jaundice monitoring system in actual home settings was analyzed. Results A total of 538 paired transcutaneous bilirubin (TcB) and total serum bilirubin (TSB) measurements showed a strong correlation (r=0.85, P<0.001), with 95.0% (511/538) of samples within the 95% limits of agreement. Using TcB ≥ the 95th percentile as the predictive indicator, the system achieved 100% sensitivity, 46.2% specificity, and an area under the receiver operating characteristic curve of 0.731 (95%CI: 0.682-0.780). This approach could reduce unnecessary hospital visits by 41.4% (221/538). Conclusions The system integrates the QBH-801 transcutaneous bilirubinometer, intelligent early warning, and remote guidance services, establishing a closed-loop "hospital-to-home" management model. It demonstrates high safety and feasibility, with significant clinical translational value.